Showing results (621-630 of 674) with videos related to
Sort By:
Pageof 68
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, James A Johnson, Andrew Viet, et al.Theranostics|July 21, 2020
LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signalingJi Liu, Rui Xu, Shi-Juan Mai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2020
Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast CancerAranzazu Fernandez-Martinez, Ian E Krop, David W Hillman, et al.Nature|October 18, 2013
Criteria for the use of omics-based predictors in clinical trialsLisa M McShane, Margaret M Cavenagh, Tracy G Lively, et al.Biomedicines|July 29, 2023
Comparative Study of the Cytokine Profiles of Serum and Tissues from Patients with the Ossification of the Posterior Longitudinal LigamentLi-Yu Fay, Chao-Hung Kuo, Hsuan-Kan Chang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast CancerJodi M Carter, Mei-Yin C Polley, Roberto A Leon-Ferre, et al.Iscience|September 10, 2019
Convergent Evolution of Mucosal Immune Responses at the Buccal Cavity of Teleost FishYong-Yao Yu, Wei-Guang Kong, Hao-Yue Xu, et al.Sensors (Basel, Switzerland)|December 14, 2011
Development of a stepping force analgesic meter for a rat arthritic modelMun Fei Yam, Lip Yee Por, Kok Khiang Peh, et al.Journal of Medicinal Chemistry|May 15, 2020
Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart FailureYoshikazu Asahina, Nicholas R Wurtz, Kazuto Arakawa, et al.Breast Cancer Research and Treatment|September 16, 2017
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancerRoberto A Leon-Ferre, Mei-Yin Polley, Heshan Liu, et al.Pageof 68